|Articles|November 17, 2022

Calyx Announces Partnership With Neosoma

Calyx Medical Imaging will extend Neosoma's AI-based neuro-oncology software device to its customers.

Calyx announced a strategic partnership with Neosoma. Through this partnership, Calyx Medical Imaging extends Neosoma HGG (High-Grade Glioma), a novel AI-based neuro-oncology software device to its worldwide customers who are developing treatments for glioblastoma.

Read more about the new partnership here.


Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content